These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 220848)

  • 1. Detection and characterization of antibody to liver cell membrane in sera from patients with chronic active liver diseases.
    Tsuji T; Araki K; Naito K; Inoue J; Nacashima H
    Acta Med Okayama; 1979 Feb; 33(1):61-6. PubMed ID: 220848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS; Sung JL; Lai MY
    Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.
    Hopf U; Meyer zum Büschenfelde KH; Arnold W
    N Engl J Med; 1976 Mar; 294(11):578-82. PubMed ID: 1107836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis B antigen in the serum in chronic liver diseases and malignant hepatoma].
    Libman E; Stojsić S; Marton B; Lemberger J
    Med Pregl; 1981; 34(9-10):389-92. PubMed ID: 6281636
    [No Abstract]   [Full Text] [Related]  

  • 5. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
    Theodoropoulos G; Nakopoulou L; Fertakis A; Papaevangelou G; Hadzis G; Kasfiki A
    Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution patterns of hepatitis B antigen in the liver. Immunofluorescence studies.
    Akeyama T; Kamada T; Koyama M; Abe H
    Arch Pathol; 1974 Oct; 98(4):252-6. PubMed ID: 4369930
    [No Abstract]   [Full Text] [Related]  

  • 7. Occurrence and significance of IgG liver membrane autoantibodies (LMA) in chronic liver diseases of different aetiology.
    Meliconi R; Stancari MV; Garagnani M; Baraldini M; Stefanini GF; Miglio F; Gasbarrini G
    Clin Exp Immunol; 1983 Mar; 51(3):565-71. PubMed ID: 6342885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases.
    Kakumu S; Arakawa Y; Goji H; Kashio T; Yata K
    Gastroenterology; 1979 Apr; 76(4):665-72. PubMed ID: 105959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
    Gessoni G; Manoni F
    Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of chronic liver diseases with the presence of serum markers of the hepatitis B virus].
    Aprosina ZG; Lopatkina TN; Iakovenko EP; Krel' PE; Saiapina ES
    Ter Arkh; 1988; 60(11):23-8. PubMed ID: 3238571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant increase in the antibody to Gal alpha 1-3Gal structure in sera of patients with hepatocellular carcinoma after transcatheter arterial embolization.
    Kashiwagi M; Ikeda Y; Iwamori M; Toda G; Nagai Y
    Cancer Res; 1989 Aug; 49(16):4396-401. PubMed ID: 2545342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum autoantibodies in hepatitis associated antigen (HAA) positive patients. A possible index of cell-mediated immunity to the associated-infective agent.
    Dudley FJ; O'Shea MJ; Sherlock S
    Clin Exp Immunol; 1973 Mar; 13(3):367-72. PubMed ID: 4349710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of antibody to hepatitis C virus (anti-HCV) in chronic liver diseases (CLD) in southern Italy.
    Amitrano L; Ascione A; Canestrini C; D'Agostino S; Iaccarino L; Vacca C; Gigliotti T
    Ital J Gastroenterol; 1990 Feb; 22(1):16-8. PubMed ID: 1966702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Liver cell membrane autoantibody (LMA) in chronic liver disease].
    Garagnani M; Meliconi R; Mazzoli M; Stancari V; Mariani AR; Morabito F; Miglio F; Facchini A
    Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1585-9. PubMed ID: 7459079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autoimmune reaction of the 'Chişiu type" in chronic liver diseases].
    Costică II; Dumitriu M; Benea F
    Med Interna (Bucur); 1973 Jun; 25(6):693-7. PubMed ID: 4793940
    [No Abstract]   [Full Text] [Related]  

  • 17. Australia antigen in liver tissue--an immunofluorescent and immunoelectron microscopic study.
    Shikata T
    Jpn J Exp Med; 1973 Aug; 43(4):231-45. PubMed ID: 4354081
    [No Abstract]   [Full Text] [Related]  

  • 18. The detection of IgG anti-hepatocyte antibodies by ELISA in sera of patients with chronic active hepatitis: correlation with disease activity.
    Wood LJ; Saar N; Searle J; Halliday JW; Powell LW
    J Clin Lab Immunol; 1985 Aug; 17(4):167-71. PubMed ID: 4068030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B antigen in liver cirrhosis and hepatocellular carcinoma.
    Bartók I; Decastello A
    Acta Hepatogastroenterol (Stuttg); 1975 Dec; 22(6):379-86. PubMed ID: 174369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG.antibody-dependent cell-mediated cytotoxicity against cultured liver cells in patients with chronic active hepatitis.
    Nonomura A; Shintani T; Ohta G
    Jpn J Exp Med; 1978 Oct; 48(5):381-92. PubMed ID: 748618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.